• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Lilly and Banner Alzheimer’s Institute in strategic research collaboration for donanemab trial

cafead

Administrator
Staff member
  • cafead   Jul 15, 2021 at 12:32: PM
via Eli Lilly and Company and Banner Alzheimer’s Institute have announced a strategic research collaboration as part of the planned Phase 3 study for donanemab in participants at risk from cognitive and functional d

article source
 

<